Committed Investment: October, 2022
Status: Active Portfolio Company
Geno.Me aims to provide the most efficient ease of access to comprehensive healthcare profiles. The company’s technology platform bundles medical records and genetic information from consenting contributors, anonymizes it, and makes it available to client/partner organizations. These organizations use the data to drive outcomes for pharmaceutical and treatment plan development. By linking medical records to genetic information, decision-making at the clinical level can be enhanced, positively impacting the health and wellness of patient populations. Thus, GenoMe’s solution makes health data more accurate, affordable, accessible, and applicable for both clinicians and researchers within a single repository. Contributors are also then compensated when their dataset is purchased.
